Nom du produit:4-(4-fluorobenzoyl)-1-(4-fluorobenzyl)-3-methyl-3,4-dihydroquinoxalin-2(1H)-one
IUPAC Name:4-(4-fluorobenzoyl)-1-[(4-fluorophenyl)methyl]-3-methyl-1,2,3,4-tetrahydroquinoxalin-2-one
- CAS:1007920-86-6
- Formule moléculaire:C23H18F2N2O2
- Pureté:95%+
- Numéro de catalogue:CM1047745
- Poids moléculaire:392.41
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1007920-86-6
- Formule moléculaire:C23H18F2N2O2
- Point de fusion:-
- Code SMILES:O=C1N(CC2=CC=C(F)C=C2)C3=C(C=CC=C3)N(C(C4=CC=C(F)C=C4)=O)C1C
- Densité:
- Numéro de catalogue:CM1047745
- Poids moléculaire:392.41
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.